RegAtrium Strategy & Advisory

Regulatory CMC & Global Strategy

How we can support you

• CMC Development Strategy

  phase-appropriate regulatory strategy across drug substance and drug product development, process development, validation and commercialisation

• Control Strategy

  development and regulatory positioning of specifications, critical quality attributes, process controls and analytical controls

• CTD Module 3 Authoring & Review

  preparation, review and coordination of CMC dossier content for global submissions

• IND, MAA & BLA Filings

  CMC strategy and submission support across development and registration

• Analytical & Stability Strategy

  regulatory strategy for analytical methods, method validation, specifications and stability programmes

• Process Validation & Manufacturing Strategy

  regulatory considerations for process validation, scale-up, technology transfer and manufacturing readiness

• Health Authority Interactions

  briefing packages, responses to questions and CMC support for agency meetings

• Comparability & Manufacturing Changes

  regulatory strategy for process, site, scale, formulation and other CMC changes

• Post-Approval Variations & Lifecycle Management

  variations, supplements and ongoing CMC lifecycle strategy

• Global Regulatory Strategy

  alignment of CMC requirements and submission approaches across major markets

Combination Products & Drug-Device Strategy

How we can support you

• Combination Product Regulatory Strategy

  integrated regulatory strategy across medicinal product, device and combination-product requirements

• Device Development & Design Controls

  regulatory guidance across device development, design planning, verification, validation and design changes

• Design & Development Documentation

  support for design-control documentation, including DHF-related documentation where applicable

• Human Factors & Usability Engineering

  regulatory strategy for use-related risk analysis, formative studies, summative validation and supporting documentation

• Device Risk Management

  alignment of device risk management, usability, design controls and regulatory evidence throughout development

• Drug-Device Submission Strategy

  integration of device documentation into IND, MAA, BLA and other global regulatory submissions

• Device & Combination Product Documentation

  preparation and review of device-related regulatory content and supporting technical documentation

• Health Authority & Notified Body Interactions

  strategy and support for regulatory questions, meetings and assessments

• Device Changes & Lifecycle Management

  regulatory assessment and strategy for design, manufacturing, supplier and other post-approval changes

• Cross-Functional Regulatory Integration

  alignment across CMC, device, quality, clinical, human factors and regulatory teams

Digital Regulatory, Data & AI

How we can support you

• Digital Regulatory Strategy

  practical roadmap for moving towards more structured, data-driven and technology-enabled regulatory ways of working

• Structured CMC & Regulatory Data

  identification and structuring of regulatory data to support consistency, reuse and better decision-making

• Data Quality & Governance

  definition of data ownership, stewardship, quality controls, standards and governance for trusted regulatory data

• Regulatory Automation

  identification and prioritisation of opportunities to reduce manual work across regulatory, CMC and data-management processes

• AI & GenAI Use Cases

  identification and design of responsible AI opportunities across regulatory and CMC workflows

• AI Governance & Guardrails

  practical governance, human oversight, quality controls and risk management for responsible AI use in regulated environments

• Data & AI Readiness Assessment

  assessment of data, technology, process, governance and workforce readiness before scaling digital or AI initiatives

• Operating Model & Capability Building

  definition of roles, responsibilities, governance and skills needed to sustain digital regulatory transformation